Braun-Bostich & Associates’s GSK GSK Stock Holding History

Braun-Bostich & Associates’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-320	Closed	-$16K	–	277
2020 Q2	$16K	Hold	320	–	–	0.02%	189
2020 Q1	$15K	Hold	320	–	–	0.02%	183
2019 Q4	$19K	Buy	+320	New	+$17.8K	0.02%	199
2019 Q3	–	Sell	-1,270	Closed	-$64K	–	173
2019 Q2	$64K	Sell	1,270 -273	-18%	-$13.7K	0.07%	173
2019 Q1	$81K	Hold	1,543	–	–	0.08%	173
2018 Q4	$74K	Sell	1,543 -421	-21%	-$20.7K	0.08%	156
2018 Q3	$99K	Hold	1,964	–	–	0.1%	139
2018 Q2	$99K	Hold	1,964	–	–	0.1%	137
2018 Q1	$96K	Sell	1,964 -978	-33%	-$45.5K	0.08%	131
2017 Q4	$130K	Buy	+2,942	New	+$136K	0.11%	127

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Braun-Bostich & Associates's GSK Position: Q3 2020 in Review

Braun-Bostich & Associates sold out of GSK (GSK) in Q3 2020, closing a stake of 320 shares — an estimated $16K sold.

Braun-Bostich & Associates first reported a position in GSK in Q4 2017 and held it in 10 quarters. The position peaked at $130K in Q4 2017. 826 funds tracked by Wall St. Rank hold GSK as of Q3 2020.

Braun-Bostich & Associates reported no remaining GSK position as of Q3 2020 after selling out during the quarter.
Braun-Bostich & Associates sold 320 GSK shares in Q3 2020, an estimated $16K.
Braun-Bostich & Associates first reported a position in GSK in Q4 2017 and held it in 10 quarters.
Braun-Bostich & Associates's GSK position peaked at $130K in Q4 2017.
826 funds tracked by Wall St. Rank held GSK as of Q3 2020.

Based on Braun-Bostich & Associates's 13F filing for Q3 2020, filed 9 Oct 2020.